collection
https://read.qxmd.com/read/31973927/pediatric-empyemas-has-the-pendulum-swung-too-far
#21
JOURNAL ARTICLE
S Christopher Derderian, Maxene Meier, David A Partrick, Gina Demasellis, Pamela D Reiter, Aparna Annam, Jennifer Bruny
BACKGROUND: The management of childhood empyemas has transformed over the past decade, with current trends favoring chest tube placement and intrapleural fibrinolytic therapy. Although this strategy often avoids the need for video-assisted thoracoscopic surgery (VATS), hospital length of stay can be long. METHODS: To characterize national trends and outcomes associated with empyema management, the Pediatric Health Information System (PHIS) database was queried to identify children (2 months-18 years) treated for an empyema between January 2010 and December 2017...
November 2020: Journal of Pediatric Surgery
https://read.qxmd.com/read/31978945/a-novel-coronavirus-from-patients-with-pneumonia-in-china-2019
#22
JOURNAL ARTICLE
Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu, Peihua Niu, Faxian Zhan, Xuejun Ma, Dayan Wang, Wenbo Xu, Guizhen Wu, George F Gao, Wenjie Tan
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans...
February 20, 2020: New England Journal of Medicine
https://read.qxmd.com/read/31986264/clinical-features-of-patients-infected-with-2019-novel-coronavirus-in-wuhan-china
#23
JOURNAL ARTICLE
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, Xuelei Xie, Wen Yin, Hui Li, Min Liu, Yan Xiao, Hong Gao, Li Guo, Jungang Xie, Guangfa Wang, Rongmeng Jiang, Zhancheng Gao, Qi Jin, Jianwei Wang, Bin Cao
BACKGROUND: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. METHODS: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing...
February 15, 2020: Lancet
https://read.qxmd.com/read/31586417/pandrug-resistant-gram-negative-bacteria-a-systematic-review-of-current-epidemiology-prognosis-and-treatment-options
#24
JOURNAL ARTICLE
Stamatis Karakonstantis, Evangelos I Kritsotakis, Achilleas Gikas
BACKGROUND: The literature on the epidemiology, mortality and treatment of pandrug-resistant (PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. OBJECTIVES: To consolidate the relevant literature and identify treatment options for PDR GNB infections. METHODS: A systematic search in MEDLINE, Scopus and clinical trial registries was conducted. Studies reporting PDR clinical isolates were eligible for review if susceptibility testing for all major antimicrobials had been performed...
February 1, 2020: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/31792548/a-guide-to-utilization-of-the-microbiology-laboratory-for-diagnosis-of-infectious-diseases-2018-update-by-the-infectious-diseases-society-of-america-and-the-american-society-for-microbiologya
#25
JOURNAL ARTICLE
J Michael Miller, Matthew J Binnicker, Sheldon Campbell, Karen C Carroll, Kimberle C Chapin, Peter H Gilligan, Mark D Gonzalez, Robert C Jerris, Sue C Kehl, Robin Patel, Bobbi S Pritt, Sandra S Richter, Barbara Robinson-Dunn, Joseph D Schwartzman, James W Snyder, Sam Telford, Elitza S Theel, Richard B Thomson, Melvin P Weinstein, Joseph D Yao
The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections...
August 31, 2018: Clinical Infectious Diseases
https://read.qxmd.com/read/31724045/epidemiology-and-diagnostics-of-carbapenem-resistance-in-gram-negative-bacteria
#26
REVIEW
Patrice Nordmann, Laurent Poirel
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow. Although carbapenemase-producing Enterobacteriaceae have received the most attention because resistance was first reported in these pathogens in the early 1990s, there is increased awareness of the impact of carbapenem-resistant nonfermenting gram-negative bacteria, such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. Moreover, evaluating the problem of carbapenem resistance requires the consideration of both carbapenemase-producing bacteria as well as bacteria with other carbapenem resistance mechanisms...
November 13, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/31722185/extended-spectrum-%C3%AE-lactamase-producing-enterobacteriaceae-carbapenem-sparing-options
#27
REVIEW
Abdullah Tarık Aslan, Murat Akova
Introduction : Carbapenems have an important place in our antibiotic armamentarium and have been trusted to effectively treat infections caused by ESBL-producing Enterobacteriaceae for many years. However, the utility of carbapenems has been compromised by the emergence of resistance especially in Enterobacteriaceae . Therefore, carbapenem-sparing alternative antibiotics are of extreme importance in clinical practice. Areas covered : We reviewed studies addressing currently available antibiotic options used as both empiric and definitive therapy for the treatment of infections due to ESBL-producing Enterobacteriaceae published in the PubMed/MEDLINE, Web of Science and Scopus databases without any date restriction...
December 2019: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/31885840/diagnosis-and-management-of-catheter-related-bloodstream-infections-in-patients-on-home-parenteral-nutrition
#28
REVIEW
Ashley Bond, Paul Chadwick, Trevor R Smith, Jeremy M D Nightingale, Simon Lal
Catheter-related bloodstream infections (CRBSIs) commonly arise from a parenteral nutrition catheter hub. A target for a Nutrition Support Team is to have a CRBSI rate of less than 1 per 1000. The diagnosis of CRBSI is suspected clinically by a temperature shortly after setting up a feed, general malaise or raised blood inflammatory markers. It is confirmed by qualitative and quantitative blood cultures from the catheter and peripherally. Treatment of inpatients may involve central venous catheter removal and antibiotics for patients needing short-term parenteral nutrition, but catheter salvage is generally recommended for patients needing long-term parenteral nutrition, where appropriate...
January 2020: Frontline Gastroenterology
https://read.qxmd.com/read/31900250/archivist-simple-strategies-for-methicillin-resistant-staphlococcus-aureus-mrsa-infection
#29
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 2020: Archives of Disease in Childhood
https://read.qxmd.com/read/31676904/guideline-for-antibacterial-prophylaxis-administration-in-pediatric-cancer-and-hematopoietic-stem-cell-transplantation
#30
JOURNAL ARTICLE
Thomas Lehrnbecher, Brian T Fisher, Bob Phillips, Sarah Alexander, Roland A Ammann, Melissa Beauchemin, Fabianne Carlesse, Elio Castagnola, Bonnie L Davis, L Lee Dupuis, Grace Egan, Andreas H Groll, Gabrielle M Haeusler, Maria Santolaya, William J Steinbach, Marianne van de Wetering, Joshua Wolf, Sandra Cabral, Paula D Robinson, Lillian Sung
BACKGROUND: Bacteremia and other invasive bacterial infections are common among children with cancer receiving intensive chemotherapy and in pediatric recipients of hematopoietic stem cell transplantation (HSCT). Systemic antibacterial prophylaxis is one approach that can be used to reduce the risk of these infections. Our purpose was to develop a clinical practice guideline (CPG) for systemic antibacterial prophylaxis administration in pediatric patients with cancer and those undergoing HSCT...
June 24, 2020: Clinical Infectious Diseases
https://read.qxmd.com/read/31724043/treatment-options-for-carbapenem-resistant-gram-negative-bacterial-infections
#31
REVIEW
Yohei Doi
Antimicrobial resistance has become one of the greatest threats to public health, with rising resistance to carbapenems being a particular concern due to the lack of effective and safe alternative treatment options. Carbapenem-resistant gram-negative bacteria of clinical relevance include the Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter baumannii, and more recently, Stenotrophomonas maltophilia. Colistin and tigecycline have been used as first-line agents for the treatment of infections caused by these pathogens; however, there are uncertainties regarding their efficacy even when used in combination with other agents...
November 13, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/31488196/host-susceptibility-to-severe-influenza-a-virus-infection
#32
REVIEW
Sara Clohisey, John Kenneth Baillie
Most people exposed to a new flu virus do not notice any symptoms. A small minority develops critical illness. Some of this extremely broad variation in susceptibility is explained by the size of the initial inoculum or the influenza exposure history of the individual; some is explained by generic host factors, such as frailty, that decrease resilience following any systemic insult. Some demographic factors (pregnancy, obesity, and advanced age) appear to confer a more specific susceptibility to severe illness following infection with influenza viruses...
September 5, 2019: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/31599334/invasive-pulmonary-aspergillosis-in-critically-ill-patients-with-hematological-malignancies
#33
MULTICENTER STUDY
Emmanuel Pardo, Virginie Lemiale, Djamel Mokart, Annabelle Stoclin, Anne-Sophie Moreau, Lionel Kerhuel, Laure Calvet, Sandrine Valade, Audrey De Jong, Michael Darmon, Elie Azoulay
PURPOSE: Invasive pulmonary aspergillosis (IPA) is a dreadful event in patients with hematological malignancies (HM). Recent advances have standardized diagnostic, prophylactic and curative therapeutic strategies. We sought to assess whether these advances actually translate into improved survival in critically ill patients with acute respiratory failure and IPA. METHODS: This was a retrospective, multicenter study. Adult patients with HM, IPA, admitted to the ICU for acute respiratory failure over a 20-year period (January 1998-December 2017) were included...
December 2019: Intensive Care Medicine
https://read.qxmd.com/read/31559876/use-of-meropenem-in-treating-carbapenem-resistant-enterobacteriaceae-infections
#34
REVIEW
Renato Pascale, Maddalena Giannella, Michele Bartoletti, Pierluigi Viale, Federico Pea
Introduction : The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing the pharmacokinetic/pharmacodynamic (PK/PD) behavior of meropenem. Areas covered : This article overviews the available literature concerning the potential role that meropenem may still have in the treatment carbapenem-resistant Enterobacteriaceae infections...
October 2019: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/31469782/risk-factors-for-influenza-virus-related-severe-lower-respiratory-tract-infection-in-children
#35
JOURNAL ARTICLE
Aykut Eşki, Gökçen Kartal Öztürk, Figen Gülen, Candan Çiçek, Esen Demir
BACKGROUND: Influenza virus is one of the most common respiratory pathogens for all age groups and may cause seasonal outbreaks. Our aim was to identify risk groups and factors associated with severe clinical course including mortality in children with influenza-related lower respiratory tract infection (LRTI). METHODS: We conducted a retrospective study in children hospitalized with influenza virus LRTI from 2008 to 2018. Data on demographic features, influenza type, viral coinfection, primary and secondary bacterial infections (SBIs), time of onset of antiviral treatment, comorbidities, hospitalization length, pediatric intensive care unit admission/invasive mechanical ventilation (IMV) need and mortality were collected from medical records...
November 2019: Pediatric Infectious Disease Journal
https://read.qxmd.com/read/31313681/severe-influenza-overview-in-critically-ill-patients
#36
REVIEW
Cristina Sarda, Pedro Palma, Jordi Rello
PURPOSE OF REVIEW: Overview of influenza infection, focusing on outcome and complications in critically ill patients. We also discuss relevant elements in immunopathogenesis and their role as predictors of severity. RECENT FINDINGS: Pandemic influenza A (H1N1) virus circulates seasonally and remains the predominant subtype among intensive care patients. Mortality in acute respiratory failure (ARF) is around 20%, independent of influenza subtypes. During severe infection, the imbalance between pro-inflammatory and anti-inflammatory molecules, such as Th1 and Th17 cytokines, is associated with complicated infections and mortality...
October 2019: Current Opinion in Critical Care
https://read.qxmd.com/read/31431428/-clostridioides-difficile-diagnosis-and-treatments
#37
REVIEW
Benoit Guery, Tatiana Galperine, Frédéric Barbut
Clostridioides difficile (formerly Clostridium ) is a major cause of healthcare associated diarrhea, and is increasingly present in the community. Historically, C difficile infection was considered easy to diagnose and treat. Over the past two decades, however, diagnostic techniques have changed in line with a greater understanding of the physiopathology of C difficile infection and the use of new therapeutic molecules. The evolution of diagnosis showed there was an important under- and misdiagnosis of C difficile infection, emphasizing the importance of algorithms recommended by European and North American infectious diseases societies to obtain a reliable diagnosis...
August 20, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/31477606/recommendations-for-prevention-and-control-of-influenza-in-children-2019-2020
#38
JOURNAL ARTICLE
(no author information available yet)
This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019-2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another...
October 2019: Pediatrics
https://read.qxmd.com/read/31189475/influenza-virus-related-critical-illness-prevention-diagnosis-treatment
#39
REVIEW
Eric J Chow, Joshua D Doyle, Timothy M Uyeki
Annual seasonal influenza epidemics of variable severity result in significant morbidity and mortality in the United States (U.S.) and worldwide. In temperate climate countries, including the U.S., influenza activity peaks during the winter months. Annual influenza vaccination is recommended for all persons in the U.S. aged 6 months and older, and among those at increased risk for influenza-related complications in other parts of the world (e.g. young children, elderly). Observational studies have reported effectiveness of influenza vaccination to reduce the risks of severe disease requiring hospitalization, intensive care unit admission, and death...
June 12, 2019: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/31324202/influenza-virus-related-critical-illness-pathophysiology-and-epidemiology
#40
REVIEW
Andre C Kalil, Paul G Thomas
Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response. In humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs through a susceptible individual's contact with aerosols or respiratory fomites from an infected individual. The inability of the lung to perform its primary function of gas exchange can result from multiple mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix...
July 19, 2019: Critical Care: the Official Journal of the Critical Care Forum
label_collection
label_collection
8042
2
3
2019-08-18 03:49:41
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.